Search research articles
Contact Us
Filters
Showing results (581-590 of 704) with videos related to
Page
of 71
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2024
Outcomes With Postrecurrence Systemic Therapy Following Adjuvant Checkpoint Inhibitor Treatment for Resected Melanoma in CheckMate 238
Jeffrey Weber, Michele Del Vecchio, Mario Mandalá, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 26, 2024
Efficacy and safety of 'Second Adjuvant' therapy with BRAF/MEK inhibitors after local therapy for recurrent melanoma following adjuvant PD-1 based immunotherapy
Amelia M Taylor, Janet McKeown, Florentia Dimitriou, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 21, 2023
The features and management of acquired resistance to PD1-based therapy in metastatic melanoma
Adriana Hepner, Judith M Versluis, Roslyn Wallace, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 16, 2024
Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
T Amaral, M Ottaviano, A Arance, et al.
Pigment Cell & Melanoma Research
|
February 16, 2019
Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti-PD-1 antibodies
Ines Pires da Silva, Isabella C Glitza, Lauren E Haydu, et al.
The Journal of Investigative Dermatology
|
November 23, 2021
Multi-Trait Genetic Analysis Identifies Autoimmune Loci Associated with Cutaneous Melanoma
Upekha E Liyanage, Stuart MacGregor, D Timothy Bishop, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 14, 2022
Adjuvant nivolumab versus ipilimumab (CheckMate 238 trial): Reassessment of 4-year efficacy outcomes in patients with stage III melanoma per AJCC-8 staging criteria
James Larkin, Jeffrey Weber, Michele Del Vecchio, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 24, 2024
Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study
Mario Mandalà, Paul Lorigan, Maria Chiara Sergi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 8, 2014
Combined BRAF (Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitor
Douglas B Johnson, Keith T Flaherty, Jeffrey S Weber, et al.
Nature Communications
|
July 2, 2026
Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years
Claus Garbe, Ulrike Keim, Teresa Amaral, et al.
Page
of 71
Search research articles
Search
Showing results (581-590 of 704) with videos related to
Sort By:
Page
of 71
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2024
Outcomes With Postrecurrence Systemic Therapy Following Adjuvant Checkpoint Inhibitor Treatment for Resected Melanoma in CheckMate 238
Jeffrey Weber, Michele Del Vecchio, Mario Mandalá, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 26, 2024
Efficacy and safety of 'Second Adjuvant' therapy with BRAF/MEK inhibitors after local therapy for recurrent melanoma following adjuvant PD-1 based immunotherapy
Amelia M Taylor, Janet McKeown, Florentia Dimitriou, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 21, 2023
The features and management of acquired resistance to PD1-based therapy in metastatic melanoma
Adriana Hepner, Judith M Versluis, Roslyn Wallace, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 16, 2024
Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
T Amaral, M Ottaviano, A Arance, et al.
Pigment Cell & Melanoma Research
|
February 16, 2019
Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti-PD-1 antibodies
Ines Pires da Silva, Isabella C Glitza, Lauren E Haydu, et al.
The Journal of Investigative Dermatology
|
November 23, 2021
Multi-Trait Genetic Analysis Identifies Autoimmune Loci Associated with Cutaneous Melanoma
Upekha E Liyanage, Stuart MacGregor, D Timothy Bishop, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 14, 2022
Adjuvant nivolumab versus ipilimumab (CheckMate 238 trial): Reassessment of 4-year efficacy outcomes in patients with stage III melanoma per AJCC-8 staging criteria
James Larkin, Jeffrey Weber, Michele Del Vecchio, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 24, 2024
Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study
Mario Mandalà, Paul Lorigan, Maria Chiara Sergi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 8, 2014
Combined BRAF (Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitor
Douglas B Johnson, Keith T Flaherty, Jeffrey S Weber, et al.
Nature Communications
|
July 2, 2026
Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years
Claus Garbe, Ulrike Keim, Teresa Amaral, et al.
Page
of 71